๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Goserelin approved for early-stage breast cancer in the UK, Czech Republic and Hungary

Book ID
120865364
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2001
Weight
151 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

BRCA1 and BRCA2 mutations in women with
BRCA1 and BRCA2 mutations in women with familial or early-onset breast/ovarian cancer in the Czech Republic
โœ Lenka Foretova; Eva Machackova; Marie Navratilova; Hana Pavlu; Marcela Hruba; Mi ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 45 KB ๐Ÿ‘ 2 views

Germline mutations in BRCA1 and BRCA2 account for majority of hereditary breast and ovarian cancer. The complete coding sequence analysis of both genes was carried out in 197 breast/ovarian cancer patients from high-risk families and 53 patients with sporadic breast/ovarian cancer. In summary, 59 mu

Trends in the use of implantable acceler
Trends in the use of implantable accelerated partial breast irradiation therapy for early stage breast cancer in the United States
โœ Andrea M. Abbott; Elizabeth B. Habermann; Todd M. Tuttle ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 183 KB ๐Ÿ‘ 2 views

## BACKGROUND: In 2002, the US Food and Drug Administration approved an implantable balloon catheter that delivers accelerated partial breast irradiation (APBI) after breast-conserving surgery (BCS). The objective of the current study was to determine the use of implantable APBI (IAPBI) in the Uni